Journal of Lipid Research
Volume 52, Issue 4, April 2011, Pages 679-687
Research ArticlesImproved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9[S]
Under a Creative Commons license
open access
cholesterol/metabolism
drug therapy
gene expression
Cited by (0)
- ALT
alanine aminotransferase
- APOB
apolipoprotein B
- AST
aspartate aminotransferase
- CE
cholesteryl ester
- DELFIA
dissociation-enhanced lanthanide fluorescence immunoassay
- FC
free cholesterol
- H and E
hematoxylin and eosin
- LDH
lactate dehydrogenase
- LDL-c
LDL cholesterol
- LDLr
LDL receptor
- LNP
lipid nanoparticle
- NBF
neutral buffered formalin
- PCSK9
proprotein convertase subtilisin/kexin type 9
- siRNA
small interfering RNA
- SREBP-2
sterol-regulatory-element-binding protein-2
Abbreviations:
- [S]
The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of eight figures and two tables.
- 2
B. Ason and S. Tep contributed equally to this work.
© 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.